NCT00457457 - Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms. | Biotech Hunter

Enrollment

609

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions

Prostatic Hyperplasia

Interventions

DRUG

Tamsulosin

Tamsulosin hydrochloride capsules, 0.4 mg. Tamsulosin hydrochloride is an antagonist of alpha1A adrenoceptors in the prostate

DRUG

UK-369,003

UK 369,003 is a highly selective and potent inhibitor of PDE5. It has increased selectivity for PDE5 over PDE6 (\>80 fold) compared to sildenafil (\~10 fold). Two recently completed trials have shown efficacy for UK-369,003 in treating subjects with ED

Trial Locations (46)

0

Pfizer Investigational Site, Medellín

Pfizer Investigational Site, Barranquilla

Pfizer Investigational Site, Bogota

Pfizer Investigational Site, Santiago de Cali

2820

Pfizer Investigational Site, Gentofte Municipality

5000

Pfizer Investigational Site, Adelaide

8200

Pfizer Investigational Site, Aarhus N

9100

Pfizer Investigational Site, Aalborg

26500

Pfizer Investigational Site, Rio

28035

Pfizer Investigational Site, Madrid

29010

Pfizer Investigational Site, Málaga

33100

Pfizer Investigational Site, Tampere

41110

Pfizer Investigational Site, Larissa

46010

Pfizer Investigational Site, Valencia

47144

Pfizer Investigational Site, Kaunas

50009

Pfizer Investigational Site, Kaunas

53100

Pfizer Investigational Site, Siena

56403

Pfizer Investigational Site, Thessaloniki

70100

Pfizer Investigational Site, Kuopio

71100

Pfizer Investigational Site, Foggia

90100

Pfizer Investigational Site, Oulu

4810371

Pfizer Investigational Site, Temuco

Unknown

Pfizer Investigational Site, Herston

Pfizer Investigational Site, Brussels

Pfizer Investigational Site, Santiago

Pfizer Investigational Site, Bogota

B-1090

Pfizer Investigational Site, Brussels

B-2650

Pfizer Investigational Site, Edegem

T2V 4R6

Pfizer Investigational Site, Calgary

N6A 4V2

Pfizer Investigational Site, London

H9R 4S3

Pfizer Investigational Site, Pointe-Claire

00100

Pfizer Investigational Site, Helsinki

LV-1002

Pfizer Investigational Site, Riga

08661

Pfizer Investigational Site, Vilnius

85-092

Pfizer Investigational Site, Bydgoszcz

85-168

Pfizer Investigational Site, Bydgoszcz

80-402

Pfizer Investigational Site, Gdansk

81-393

Pfizer Investigational Site, Gdynia

41-400

Pfizer Investigational Site, Mysłowice

84-200

Pfizer Investigational Site, Wejherowo

851 01

Pfizer Investigational Site, Bratislava

901 01

Pfizer Investigational Site, Malacky

949 01

Pfizer Investigational Site, Nitra

080 01

Pfizer Investigational Site, Prešov

909 82

Pfizer Investigational Site, Skalica

BS2 8HW

Pfizer Investigational Site, Bristol